APA (7th ed.) Citation

J, W., P, L., DW, L., Y, C., HZ, M., BG, L., . . . GR, W. (2016). GSK-3β inhibitor attenuates urinary albumin excretion in type 2 diabetic db/db mice, and delays epithelial-to-mesenchymal transition in mouse kidneys and podocytes. Molecular medicine reports, 14(2), 1771. https://doi.org/10.3892/mmr.2016.5441

Chicago Style (17th ed.) Citation

J, Wan, et al. "GSK-3β Inhibitor Attenuates Urinary Albumin Excretion in Type 2 Diabetic Db/db Mice, and Delays Epithelial-to-mesenchymal Transition in Mouse Kidneys and Podocytes." Molecular Medicine Reports 14, no. 2 (2016): 1771. https://doi.org/10.3892/mmr.2016.5441.

MLA (9th ed.) Citation

J, Wan, et al. "GSK-3β Inhibitor Attenuates Urinary Albumin Excretion in Type 2 Diabetic Db/db Mice, and Delays Epithelial-to-mesenchymal Transition in Mouse Kidneys and Podocytes." Molecular Medicine Reports, vol. 14, no. 2, 2016, p. 1771, https://doi.org/10.3892/mmr.2016.5441.